EPZM - Epizyme's (EPZM) CEO Grant Bogle on Q4 2021 Results - Earnings Call Transcript
Epizyme, Inc. (EPZM) Q4 2021 Earnings Conference Call March 1, 2022 8:30 AM ET Company Participants Grant Bogle – President and Chief Executive Officer Shefali Agarwal – Executive Vice President, Chief Medical and Development Officer Conference Call Participants Joseph Thome – Cowen Peter Lawson – Barclays David Nierengarten – Wedbush Presentation Operator Hello, and welcome to the Epizyme Fourth Quarter and Full Year 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following the prepared remarks, there will be a question-and-answer session. Please be advised that today’s call is being recorded. I will now turn the call over to Kristen Hilton [ph], Investor Relations. You may begin. Unidentified Company Representative Thank you, operator. This morning, Epizyme issued a press release providing a business update in addition to fourth quarter and full year 2021 financial results. That press release can be found in the Investors
For further details see:
Epizyme's (EPZM) CEO Grant Bogle on Q4 2021 Results - Earnings Call Transcript